The transwell cells positive rates were added up to 38.5%, 41.5%, 69.8% in HULC, MALAT1, HULC plus MALAT1 overexpressed liver cancer stem cells, as well as the transwell cells positive rate was 16.5% in control (t-test, P < 0.01). Here, MALAT1 is linked to liver cancer.